ImmuPharma PLC
LSE:IMM
ImmuPharma PLC
LSE:IMM
Price:
4.64
GBX
-6.45%
Market Closed
Market Cap:
£23.3m
Income Statement
Earnings Waterfall
ImmuPharma PLC
ImmuPharma PLC
Income Statement
ImmuPharma PLC
ImmuPharma PLC
Currency: GBP
| Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
-41%
|
0
-76%
|
0
+297%
|
0
+65%
|
0
-1%
|
0
-31%
|
0
+53%
|
0
-12%
|
0
+20%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(8)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(5)
|
(5)
|
(3)
|
(3)
|
(3)
|
(4)
|
(2)
|
(3)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(5)
|
(5)
|
0
|
(3)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(8)
N/A
|
(8)
+1%
|
(7)
+11%
|
(6)
+13%
|
(6)
+7%
|
(6)
+4%
|
(6)
-4%
|
(7)
-19%
|
(5)
+25%
|
(5)
+7%
|
(3)
+37%
|
(3)
+12%
|
(3)
-15%
|
(4)
-25%
|
(2)
+41%
|
(3)
-21%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
(1)
|
(0)
|
0
|
(2)
|
(2)
|
0
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(8)
N/A
|
(8)
+2%
|
(8)
+1%
|
(7)
+15%
|
(6)
+15%
|
(7)
-27%
|
(8)
-11%
|
(11)
-32%
|
(9)
+15%
|
(9)
-5%
|
(4)
+53%
|
(4)
+15%
|
(3)
+9%
|
(4)
-17%
|
(3)
+31%
|
(4)
-49%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
|
| Income from Continuing Operations |
(7)
|
(7)
|
(7)
|
(6)
|
(5)
|
(7)
|
(8)
|
(10)
|
(8)
|
(8)
|
(4)
|
(3)
|
(3)
|
(3)
|
(2)
|
(4)
|
|
| Net Income (Common) |
(7)
N/A
|
(7)
+1%
|
(7)
+2%
|
(6)
+13%
|
(5)
+15%
|
(7)
-32%
|
(8)
-10%
|
(10)
-30%
|
(8)
+17%
|
(6)
+24%
|
(4)
+38%
|
(3)
+21%
|
(3)
+2%
|
(3)
-13%
|
(2)
+25%
|
(4)
-58%
|
|
| EPS (Diluted) |
-0.05
N/A
|
-0.05
N/A
|
-0.05
N/A
|
-0.04
+20%
|
-0.03
+25%
|
-0.03
N/A
|
-0.03
N/A
|
-0.04
-33%
|
-0.03
+25%
|
-0.03
N/A
|
-0.01
+67%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
